☰

Lance A. Johnson, Ph.D. - Publications

Affiliations: 
2011 Pathology University of North Carolina, Chapel Hill, Chapel Hill, NC 
Area:
Pathology
Tree Info Grants Similar researchers PubMed Report error

47 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Cho J, Alexander KL, Ferrell JL, Johnson LA, Estus S, D'Orazio SEF. Apolipoprotein E genotype affects innate susceptibility to infection in aged male mice. Infection and Immunity. e0025123. PMID 37594272 DOI: 10.1128/iai.00251-23  0.359
2023 Lee S, Devanney NA, Golden LR, Smith CT, Schwartz JL, Walsh AE, Clarke HA, Goulding DS, Allenger EJ, Morillo-Segovia G, Friday CM, Gorman AA, Hawkinson TR, MacLean SM, Williams HC, ... ... Johnson LA, et al. APOE modulates microglial immunometabolism in response to age, amyloid pathology, and inflammatory challenge. Cell Reports. 42: 112196. PMID 36871219 DOI: 10.1016/j.celrep.2023.112196  0.367
2022 Zajac DJ, Green SJ, Johnson LA, Estus S. APOE genetics influence murine gut microbiome. Scientific Reports. 12: 1906. PMID 35115575 DOI: 10.1038/s41598-022-05763-1  0.387
2022 Seaks CE, Weekman EM, Sudduth TL, Xie K, Wasek B, Fardo DW, Johnson LA, Bottiglieri T, Wilcock DM. Apolipoprotein E ε4/4 genotype limits response to dietary induction of hyperhomocysteinemia and resulting inflammatory signaling. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 271678X211069006. PMID 35023380 DOI: 10.1177/0271678X211069006  0.433
2021 Farmer BC, Williams HC, Devanney NA, Piron MA, Nation GK, Carter DJ, Walsh AE, Khanal R, Young LEA, Kluemper JC, Hernandez G, Allenger EJ, Mooney R, Golden LR, Smith CT, ... ... Johnson LA, et al. APOΕ4 lowers energy expenditure in females and impairs glucose oxidation by increasing flux through aerobic glycolysis. Molecular Neurodegeneration. 16: 62. PMID 34488832 DOI: 10.1186/s13024-021-00483-y  0.79
2020 Williams HC, Piron MA, Nation GK, Walsh AE, Young LEA, Sun RC, Johnson LA. Oral Gavage Delivery of Stable Isotope Tracer for In Vivo Metabolomics. Metabolites. 10. PMID 33302448 DOI: 10.3390/metabo10120501  0.31
2020 Farmer BC, Walsh AE, Kluemper JC, Johnson LA. Lipid Droplets in Neurodegenerative Disorders. Frontiers in Neuroscience. 14: 742. PMID 32848541 DOI: 10.3389/Fnins.2020.00742  0.766
2020 Johnson LA. APOE and metabolic dysfunction in Alzheimer's disease. International Review of Neurobiology. 154: 131-151. PMID 32739002 DOI: 10.1016/Bs.Irn.2020.02.002  0.458
2020 Butterfield DA, Johnson LA. APOE in Alzheimer's disease and neurodegeneration. Neurobiology of Disease. 104847. PMID 32209402 DOI: 10.1016/J.Nbd.2020.104847  0.313
2020 Martínez-Martínez AB, Torres-Perez E, Devanney N, Del Moral R, Johnson LA, Arbones-Mainar JM. Beyond the CNS: The many peripheral roles of APOE. Neurobiology of Disease. 138: 104809. PMID 32087284 DOI: 10.1016/J.Nbd.2020.104809  0.438
2020 Williams HC, Farmer BC, Piron MA, Walsh AE, Bruntz R, Gentry M, Sun RC, Johnson LA. APOE alters glucose flux through central carbon pathways in astrocytes. Neurobiology of Disease. 104742. PMID 31931141 DOI: 10.1016/J.Nbd.2020.104742  0.802
2020 Johnson LA. APOE at the BBB: Pericyte-Derived Apolipoprotein E4 Diminishes Endothelial Cell Barrier Function. Arteriosclerosis, Thrombosis, and Vascular Biology. 40: 14-16. PMID 31869265 DOI: 10.1161/Atvbaha.119.313627  0.35
2019 Farmer BC, Kluemper J, Johnson LA. Apolipoprotein E4 Alters Astrocyte Fatty Acid Metabolism and Lipid Droplet Formation. Cells. 8. PMID 30791549 DOI: 10.3390/cells8020182  0.372
2019 Farmer BC, Kluemper J, Johnson LA. Apolipoprotein E4 Alters Astrocyte Fatty Acid Metabolism and Lipid Droplet Formation. Cells. 8. PMID 30791549 DOI: 10.3390/Cells8020182  0.798
2019 Farmer BC, Kluemper J, Johnson L. P1-192: Apolipoprotein E4 Promotes Lipid Droplet Accumulation In Astrocytes Alzheimers & Dementia. 15. DOI: 10.1016/J.Jalz.2019.06.747  0.385
2019 Williams HC, Brandon JA, Sun R, Johnson L. P4-118: Cerebral Metabolism And Alzheimer'S Disease Risk: Investigating The Role Of Apoe Using Stable-Isotope Resolved Metabolomics Alzheimers & Dementia. 15. DOI: 10.1016/J.Jalz.2019.06.3779  0.37
2019 Nation GK, Farmer BC, Carter DJ, Khanal R, Johnson L. P3-107: Early-Life Changes In Peripheral Metabolism: A Study Of Apoe Genotype Effects Using Indirect Calorimetry Alzheimers & Dementia. 15. DOI: 10.1016/J.Jalz.2019.06.3135  0.329
2018 Farmer BC, Johnson LA, Hanson AJ. Effects of apolipoprotein E on nutritional metabolism in dementia. Current Opinion in Lipidology. PMID 30550413 DOI: 10.1097/Mol.0000000000000566  0.795
2018 Zhou Z, Austin GL, Young LEA, Johnson LA, Sun R. Mitochondrial Metabolism in Major Neurological Diseases. Cells. 7. PMID 30477120 DOI: 10.3390/Cells7120229  0.323
2018 Johnson LA, Zuloaga DG, Bidiman E, Marzulla T, Weber S, Wahbeh H, Raber J. Correction: ApoE2 Exaggerates PTSD-Related Behavioral, Cognitive, and Neuroendocrine Alterations. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 30459445 DOI: 10.1038/S41386-018-0261-Z  0.48
2018 Brandon JA, Farmer BC, Williams HC, Johnson LA. and Alzheimer's Disease: Neuroimaging of Metabolic and Cerebrovascular Dysfunction. Frontiers in Aging Neuroscience. 10: 180. PMID 29962946 DOI: 10.3389/Fnagi.2018.00180  0.791
2018 Miranda CL, Johnson LA, de Montgolfier O, Elias VD, Ullrich LS, Hay JJ, Paraiso IL, Choi J, Reed RL, Revel JS, Kioussi C, Bobe G, Iwaniec UT, Turner RT, Katzenellenbogen BS, et al. Non-estrogenic Xanthohumol Derivatives Mitigate Insulin Resistance and Cognitive Impairment in High-Fat Diet-induced Obese Mice. Scientific Reports. 8: 613. PMID 29330372 DOI: 10.1038/S41598-017-18992-6  0.636
2017 Johnson LA, Torres ER, Weber Boutros S, Patel E, Akinyeke T, Alkayed NJ, Raber J. Apolipoprotein E4 mediates insulin resistance-associated cerebrovascular dysfunction and the post-prandial response. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 271678X17746186. PMID 29215310 DOI: 10.1177/0271678X17746186  0.809
2017 Johnson LA, Torres ER, Impey S, Stevens JF, Raber J. Apolipoprotein E4 and Insulin Resistance Interact to Impair Cognition and Alter the Epigenome and Metabolome. Scientific Reports. 7: 43701. PMID 28272510 DOI: 10.1038/Srep43701  0.808
2016 Stevens JF, Johnson L, Miranda CL, Elias VD, Hay JJ, Raber J. Xanthohumol and its derivatives mitigate metabolic syndrome and associated cognitive impairments in obese C57BL/6J mice. Planta Medica. 81: S1-S381. PMID 27976316 DOI: 10.1055/S-0036-1596132  0.589
2016 Arbones-Mainar JM, Johnson LA, Torres-Perez E, Garcia AE, Perez-Diaz S, Raber J, Maeda N. Metabolic shifts towards fatty acid usage and increased thermogenesis are associated with impaired adipogenesis in mice expressing human APOE4. International Journal of Obesity (2005). PMID 27163745 DOI: 10.1038/Ijo.2016.93  0.714
2016 Johnson LA, Zuloaga KL, Kugelman TL, Mader KS, Morré JT, Zuloaga DG, Weber S, Marzulla T, Mulford A, Button D, Lindner JR, Alkayed NJ, Stevens JF, Raber J. Amelioration of Metabolic Syndrome-Associated Cognitive Impairments in Mice via a Reduction in Dietary Fat Content or Infusion of Non-Diabetic Plasma. Ebiomedicine. 3: 26-42. PMID 26870815 DOI: 10.1016/J.Ebiom.2015.12.008  0.608
2015 Zuloaga KL, Johnson LA, Roese NE, Marzulla T, Zhang W, Nie X, Alkayed FN, Hong C, Grafe MR, Pike MM, Raber J, Alkayed NJ. High fat diet-induced diabetes in mice exacerbates cognitive deficit due to chronic hypoperfusion. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. PMID 26661233 DOI: 10.1177/0271678X15616400  0.568
2015 Zuloaga DG, Johnson LA, Weber S, Raber J. Immediate and lasting effects of chronic daily methamphetamine exposure on activation of cells in hypothalamic-pituitary-adrenal axis-associated brain regions. Psychopharmacology. PMID 26525566 DOI: 10.1007/S00213-015-4114-8  0.446
2015 Johnson LA, Zuloaga DG, Bidiman E, Marzulla T, Weber S, Wahbeh H, Raber J. ApoE2 Exaggerates PTSD-Related Behavioral, Cognitive, and Neuroendocrine Alterations. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 25857685 DOI: 10.1038/Npp.2015.95  0.594
2014 Perez-Diaz S, Johnson LA, DeKroon RM, Moreno-Navarrete JM, Alzate O, Fernandez-Real JM, Maeda N, Arbones-Mainar JM. Polymerase I and transcript release factor (PTRF) regulates adipocyte differentiation and determines adipose tissue expandability. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 28: 3769-79. PMID 24812087 DOI: 10.1096/Fj.14-251165  0.613
2014 Johnson LA, Olsen RH, Merkens LS, DeBarber A, Steiner RD, Sullivan PM, Maeda N, Raber J. Apolipoprotein E-low density lipoprotein receptor interaction affects spatial memory retention and brain ApoE levels in an isoform-dependent manner. Neurobiology of Disease. 64: 150-62. PMID 24412220 DOI: 10.1016/J.Nbd.2013.12.016  0.699
2014 Zuloaga DG, Johnson LA, Agam M, Raber J. Sex differences in activation of the hypothalamic-pituitary-adrenal axis by methamphetamine. Journal of Neurochemistry. 129: 495-508. PMID 24400874 DOI: 10.1111/Jnc.12651  0.493
2013 Haley GE, Yeiser L, Olsen RH, Davis MJ, Johnson LA, Raber J. Early effects of whole-body (56)Fe irradiation on hippocampal function in C57BL/6J mice. Radiation Research. 179: 590-6. PMID 23510274 DOI: 10.1667/Rr2946.1  0.534
2013 Olsen RH, Johnson LA, Zuloaga DG, Limoli CL, Raber J. Enhanced hippocampus-dependent memory and reduced anxiety in mice over-expressing human catalase in mitochondria. Journal of Neurochemistry. 125: 303-13. PMID 23383735 DOI: 10.1111/Jnc.12187  0.589
2013 Johnson LA, Kim HS, Knudson MJ, Nipp CT, Yi X, Maeda N. Diabetic atherosclerosis in APOE*4 mice: synergy between lipoprotein metabolism and vascular inflammation. Journal of Lipid Research. 54: 386-96. PMID 23204275 DOI: 10.1194/Jlr.M031435  0.617
2012 Pendse AA, Johnson LA, Kim HS, McNair M, Nipp CT, Wilhelm C, Maeda N. Pro- and antiatherogenic effects of a dominant-negative P465L mutation of peroxisome proliferator-activated receptor-γ in apolipoprotein E-Null mice. Arteriosclerosis, Thrombosis, and Vascular Biology. 32: 1436-44. PMID 22539598 DOI: 10.1161/Atvbaha.112.248682  0.801
2011 Johnson LA, Arbones-Mainar JM, Fox RG, Pendse AA, Altenburg MK, Kim HS, Maeda N. Apolipoprotein E4 exaggerates diabetic dyslipidemia and atherosclerosis in mice lacking the LDL receptor. Diabetes. 60: 2285-94. PMID 21810592 DOI: 10.2337/Db11-0466  0.758
2010 Johnson LA, Maeda N. Macrovascular complications of diabetes in atherosclerosisprone mice. Expert Review of Endocrinology & Metabolism. 5: 89-98. PMID 30934383 DOI: 10.1586/Eem.09.66  0.503
2010 Pendse AA, Johnson LA, Tsai YS, Maeda N. Pparg-P465L mutation worsens hyperglycemia in Ins2-Akita female mice via adipose-specific insulin resistance and storage dysfunction. Diabetes. 59: 2890-7. PMID 20724579 DOI: 10.2337/Db10-0673  0.777
2010 Arbones-Mainar JM, Johnson LA, Altenburg MK, Kim HS, Maeda N. Impaired adipogenic response to thiazolidinediones in mice expressing human apolipoproteinE4. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 24: 3809-18. PMID 20501792 DOI: 10.1096/Fj.10-159517  0.82
2009 Pendse AA, Arbones-Mainar JM, Johnson LA, Altenburg MK, Maeda N. Apolipoprotein E knock-out and knock-in mice: atherosclerosis, metabolic syndrome, and beyond. Journal of Lipid Research. 50: S178-82. PMID 19060252 DOI: 10.1194/Jlr.R800070-Jlr200  0.802
2008 Arbones-Mainar JM, Johnson LA, Altenburg MK, Maeda N. Differential modulation of diet-induced obesity and adipocyte functionality by human apolipoprotein E3 and E4 in mice. International Journal of Obesity (2005). 32: 1595-605. PMID 18725890 DOI: 10.1038/Ijo.2008.143  0.817
2008 Johnson LA, Altenburg MK, Walzem RL, Scanga LT, Maeda N. Absence of hyperlipidemia in LDL receptor-deficient mice having apolipoprotein B100 without the putative receptor-binding sequences. Arteriosclerosis, Thrombosis, and Vascular Biology. 28: 1745-52. PMID 18617647 DOI: 10.1161/Atvbaha.108.169680  0.782
2008 Altenburg M, Arbones-Mainar J, Johnson L, Wilder J, Maeda N. Human LDL receptor enhances sequestration of ApoE4 and VLDL remnants on the surface of hepatocytes but not their internalization in mice. Arteriosclerosis, Thrombosis, and Vascular Biology. 28: 1104-10. PMID 18369154 DOI: 10.1161/Atvbaha.108.164863  0.804
2007 Maeda N, Johnson L, Kim S, Hagaman J, Friedman M, Reddick R. Anatomical differences and atherosclerosis in apolipoprotein E-deficient mice with 129/SvEv and C57BL/6 genetic backgrounds. Atherosclerosis. 195: 75-82. PMID 17275002 DOI: 10.1016/J.Atherosclerosis.2006.12.006  0.602
2007 Altenburg M, Johnson L, Wilder J, Maeda N. Apolipoprotein E4 in macrophages enhances atherogenesis in a low density lipoprotein receptor-dependent manner. The Journal of Biological Chemistry. 282: 7817-24. PMID 17234631 DOI: 10.1074/Jbc.M610712200  0.797
Show low-probability matches.